Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches
General Psychiatry December 1, 2019 Éric Bui, Franklin King, Andrew Melaragno 14 citations
Progress in developing new medications for anxiety and stress-related disorders has been limited over the past 30 years, but researchers are now investigating novel molecular pathways beyond the traditional monoamine systems. Enhancing psychotherapy with pharmacological compounds could transform the standard of care and introduce a paradigm shift in how medications are conceptualized in psychiatric treatment. More human trials and translational research are needed, but pursuing innovative mechanisms is expected to yield substantial results and move beyond the reliance on 20th-century chemical agents.